Stealth BioTherapeutics Corp (NASDAQ:MITO) went up by 8.39% from its latest closing price compared to the recent 1-year high of $2.58. The company’s stock price has collected -1.27% of loss in the last five trading sessions. Press Release reported on 04/06/21 that Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights
Is It Worth Investing in Stealth BioTherapeutics Corp (NASDAQ :MITO) Right Now?
Opinions of the stock are interesting as 1 analysts out of 2 who provided ratings for Stealth BioTherapeutics Corp declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $3.00. MITO currently public float of 13.06M and currently shorts hold a 0.68% ratio of that float. Today, the average trading volume of MITO was 419.93K shares.
MITO’s Market Performance
MITO stocks went down by -1.27% for the week, with a monthly drop of -8.82% and a quarterly performance of 9.15%, while its annual performance rate touched 15.67%. The volatility ratio for the week stands at 10.49% while the volatility levels for the past 30 days are set at 7.93% for Stealth BioTherapeutics Corp. The simple moving average for the period of the last 20 days is -7.13% for MITO stocks with a simple moving average of -4.25% for the last 200 days.
Analysts’ Opinion of MITO
Many brokerage firms have already submitted their reports for MITO stocks, with ROTH Capital repeating the rating for MITO by listing it as a “Buy.” The predicted price for MITO in the upcoming period, according to ROTH Capital is $9 based on the research report published on April 14th of the previous year 2020.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see MITO reach a price target of $5. The rating they have provided for MITO stocks is “Buy” according to the report published on April 02nd, 2020.
H.C. Wainwright gave a rating of “Neutral” to MITO, setting the target price at $5 in the report published on December 23rd of the previous year.
MITO Trading at -11.86% from the 50-Day Moving Average
After a stumble in the market that brought MITO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.92% of loss for the given period.
Volatility was left at 7.93%, however, over the last 30 days, the volatility rate increased by 10.49%, as shares sank -4.91% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.92% lower at present.
During the last 5 trading sessions, MITO fell by -1.27%, which changed the moving average for the period of 200-days by -24.95% in comparison to the 20-day moving average, which settled at $1.6650. In addition, Stealth BioTherapeutics Corp saw 3.68% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for MITO
Current profitability levels for the company are sitting at:
- -217.35 for the present operating margin
The net margin for Stealth BioTherapeutics Corp stands at -340.15. Equity return is now at value -421.90, with -100.30 for asset returns.
Based on Stealth BioTherapeutics Corp (MITO), the company’s capital structure generated 94.06 points at debt to equity in total, while total debt to capital is 48.47. Total debt to assets is 30.79, with long-term debt to equity ratio resting at 8.84. Finally, the long-term debt to capital ratio is 4.55.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.54.